METOLAZONE
- Product NDC
- 62332-532
- 11-digit product format
- 623320532
- Labeler code
- 62332
- Product ID
- 62332-532_4e197913-c368-474d-a147-e9ade3021e37
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- METOLAZONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA213251
- Marketing category
- ANDA
- Marketing start
- 2020-12-02
- Substance
- METOLAZONE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- METOLAZONE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOLAZONE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | TZ7V40X7VX |
| Rxcui | 197978, 197979, 311671 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62332-532-31 | METOLAZONE | 100 in 1 BOTTLE | TABLET | 100 | | 9 |
| 62332-532-91 | METOLAZONE | 1000 in 1 BOTTLE | TABLET | 1000 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62332-532 | METOLAZONE TABLET [ALEMBIC PHARMACEUTICALS INC.] | 9 | Current NDC, Legacy NDC, 2 package rows | 20240523_a84dbb37-648e-42d4-8688-ac39599284f0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62332-532-31 | 62332053231 | 100 TABLET in 1 BOTTLE (62332-532-31) | 100 tablet | 2020-12-02 | 0000-00-00 | No | No | Current |
| 62332-532-91 | 62332053291 | 1000 TABLET in 1 BOTTLE (62332-532-91) | 1000 tablet | 2020-12-02 | 0000-00-00 | No | No | Current |